uftoral has been researched along with Fibrosarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, S; Habelhah, H; Hosokawa, M; Kobayashi, M; Konishi, Y; Nakae, D; Okada, F; Totsuka, Y | 1 |
1 other study(ies) available for uftoral and Fibrosarcoma
Article | Year |
---|---|
Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemotaxis; Cisplatin; Clone Cells; Drug Combinations; Drug Resistance, Neoplasm; Female; Fibrosarcoma; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; RNA, Messenger; RNA, Neoplasm; Tegafur; Tissue Inhibitor of Metalloproteinase-1; Tumor Cells, Cultured; Uracil | 1999 |